这是一篇来自已证抗体库的有关Rhesus mon.. 肿瘤坏死因子 (TNF) 的综述，是根据47篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合肿瘤坏死因子 抗体。
肿瘤坏死因子 同义词: TNF-ALPHA; TNLG1F; tumor necrosis factor; ATP-binding cassette, sub-family F (GCN20), member 1; TNF-a; cachectin; tumor necrosis factor (TNF superfamily, member 2); tumor necrosis factor alpha; tumor necrosis factor ligand 1F; tumor necrosis factor ligand superfamily member 2

BioLegend
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 图 3a
BioLegend肿瘤坏死因子抗体（BioLegend, 502930)被用于被用于流式细胞仪在人类样本上 (图 3a). Cell (2019) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 图 2d
BioLegend肿瘤坏死因子抗体（BioLegend, 502930)被用于被用于流式细胞仪在人类样本上 (图 2d). Cell Rep (2018) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 图 8d
BioLegend肿瘤坏死因子抗体（Biolegend, Mab11)被用于被用于流式细胞仪在人类样本上 (图 8d). Nat Commun (2018) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 1:50; 图 1e
BioLegend肿瘤坏死因子抗体（Biolegend, 502928)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 1e). Nat Med (2019) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 图 3c
BioLegend肿瘤坏死因子抗体（BioLegend, 502927)被用于被用于流式细胞仪在人类样本上 (图 3c). J Exp Med (2018) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 图 3a
BioLegend肿瘤坏死因子抗体（BioLegend, 502909)被用于被用于流式细胞仪在人类样本上 (图 3a). J Clin Invest (2018) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 图 7a
BioLegend肿瘤坏死因子抗体（Biolegend, 502944)被用于被用于流式细胞仪在人类样本上 (图 7a). Cell Rep (2018) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 图 3b
BioLegend肿瘤坏死因子抗体（BioLegend, Mab11)被用于被用于流式细胞仪在人类样本上 (图 3b). J Exp Med (2018) ncbi
小鼠 单克隆（MAb11）
  • 酶联免疫吸附测定; 人类; 图 3d
BioLegend肿瘤坏死因子抗体（BioLegend, 502915)被用于被用于酶联免疫吸附测定在人类样本上 (图 3d). Nat Commun (2018) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 图 2h
BioLegend肿瘤坏死因子抗体（BioLegend, Mab11)被用于被用于流式细胞仪在人类样本上 (图 2h). J Clin Invest (2018) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 图 1f
BioLegend肿瘤坏死因子抗体（BioLegend, MAb11)被用于被用于流式细胞仪在人类样本上 (图 1f). Immun Inflamm Dis (2018) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 图 2b
BioLegend肿瘤坏死因子抗体（Biolegend, Mab11)被用于被用于流式细胞仪在人类样本上 (图 2b). Front Immunol (2017) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 图 s2b
BioLegend肿瘤坏死因子抗体（Biolegend, Mab11)被用于被用于流式细胞仪在人类样本上 (图 s2b). Nature (2017) ncbi
小鼠 单克隆（MAb11）
  • mass cytometry; 人类; 图 2a
BioLegend肿瘤坏死因子抗体（BioLegend, MAb11)被用于被用于mass cytometry在人类样本上 (图 2a). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 图 5b
BioLegend肿瘤坏死因子抗体（Biolegend, 502920)被用于被用于流式细胞仪在人类样本上 (图 5b). PLoS Pathog (2017) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 图 4c
BioLegend肿瘤坏死因子抗体（BioLegend, 502920)被用于被用于流式细胞仪在人类样本上 (图 4c). Oncoimmunology (2017) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 图 2a
BioLegend肿瘤坏死因子抗体（BioLegend, 502920)被用于被用于流式细胞仪在人类样本上 (图 2a). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 表 s9
BioLegend肿瘤坏死因子抗体（BioLegend, 502937)被用于被用于流式细胞仪在人类样本上 (表 s9). Nature (2017) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 猕猴
BioLegend肿瘤坏死因子抗体（Biolegend, MAb11)被用于被用于流式细胞仪在猕猴样本上. PLoS Pathog (2016) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 表 1
BioLegend肿瘤坏死因子抗体（BioLegend, MAb11)被用于被用于流式细胞仪在人类样本上 (表 1). J Exp Med (2017) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 图 1a
BioLegend肿瘤坏死因子抗体（Biolegend, 502906)被用于被用于流式细胞仪在人类样本上 (图 1a). Retrovirology (2016) ncbi
小鼠 单克隆（MAb11）
  • 抑制或激活实验; 人类; 图 6a
BioLegend肿瘤坏死因子抗体（BioLegend, Mab11)被用于被用于抑制或激活实验在人类样本上 (图 6a). Sci Rep (2016) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 1:10; 图 7b
BioLegend肿瘤坏死因子抗体（BioLegend, 502930)被用于被用于流式细胞仪在人类样本上浓度为1:10 (图 7b). Nat Biotechnol (2016) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 图 2e
BioLegend肿瘤坏死因子抗体（BioLegend, MAb11)被用于被用于流式细胞仪在人类样本上 (图 2e). J Clin Invest (2016) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 图 s9f
BioLegend肿瘤坏死因子抗体（Biolegend, MAb11)被用于被用于流式细胞仪在人类样本上 (图 s9f). Nature (2016) ncbi
小鼠 单克隆（MAb11）
BioLegend肿瘤坏死因子抗体（Biolegend, 502929)被用于. Nat Commun (2016) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 图 s1e
BioLegend肿瘤坏死因子抗体（Biolegend, MAb11)被用于被用于流式细胞仪在人类样本上 (图 s1e). Eur J Immunol (2016) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 图 6a
BioLegend肿瘤坏死因子抗体（Biolegend, MAb11)被用于被用于流式细胞仪在人类样本上 (图 6a). PLoS ONE (2016) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 猕猴
BioLegend肿瘤坏死因子抗体（BioLegend, 502920)被用于被用于流式细胞仪在猕猴样本上. Nat Med (2016) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; African green monkey; 图 1b
BioLegend肿瘤坏死因子抗体（BioLegend, Mab11)被用于被用于流式细胞仪在African green monkey样本上 (图 1b). J Med Primatol (2016) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 猪; 图 7d
BioLegend肿瘤坏死因子抗体（Biolegend, MAb11)被用于被用于流式细胞仪在猪样本上 (图 7d). PLoS ONE (2016) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 图 1
BioLegend肿瘤坏死因子抗体（Biolegend, MAb11)被用于被用于流式细胞仪在人类样本上 (图 1). J Immunol (2016) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 图 4b
BioLegend肿瘤坏死因子抗体（BioLegend, MAb11)被用于被用于流式细胞仪在人类样本上 (图 4b). Clin Cancer Res (2016) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 图 3a
BioLegend肿瘤坏死因子抗体（biolegend, MAb11)被用于被用于流式细胞仪在人类样本上 (图 3a). J Immunol (2016) ncbi
小鼠 单克隆（MAb11）
  • 免疫细胞化学; 人类; 图 6
BioLegend肿瘤坏死因子抗体（BioLegend, MAb11)被用于被用于免疫细胞化学在人类样本上 (图 6). J Hematol Oncol (2015) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 图 1
BioLegend肿瘤坏死因子抗体（Biolegend, MAb11)被用于被用于流式细胞仪在人类样本上 (图 1). Mucosal Immunol (2016) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 猪
BioLegend肿瘤坏死因子抗体（BioLegend, MAb11)被用于被用于流式细胞仪在猪样本上. Vet Res (2015) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 2 ul/test
BioLegend肿瘤坏死因子抗体（Biolegend, MAb11)被用于被用于流式细胞仪在人类样本上浓度为2 ul/test. J Immunol Methods (2015) ncbi
小鼠 单克隆（MAb11）
  • dot blot; 人类; 表 s1
BioLegend肿瘤坏死因子抗体（Biolegend, 502902)被用于被用于dot blot在人类样本上 (表 s1). Proc Natl Acad Sci U S A (2015) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 图 1
BioLegend肿瘤坏死因子抗体（Biolegend, MAb11)被用于被用于流式细胞仪在人类样本上 (图 1). J Infect Dis (2015) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 猪
BioLegend肿瘤坏死因子抗体（BioLegend, MAb11)被用于被用于流式细胞仪在猪样本上. Mol Immunol (2015) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 10 mg/ml; 图 3
BioLegend肿瘤坏死因子抗体（BioLegend, MAb11)被用于被用于流式细胞仪在人类样本上浓度为10 mg/ml (图 3). J Surg Res (2015) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 1:20
BioLegend肿瘤坏死因子抗体（BioLegend, MAb11)被用于被用于流式细胞仪在人类样本上浓度为1:20. Nat Med (2014) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类
BioLegend肿瘤坏死因子抗体（BioLegend, Mab11)被用于被用于流式细胞仪在人类样本上. Virol J (2014) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 图 3a
BioLegend肿瘤坏死因子抗体（BioLegend, MAb11)被用于被用于流式细胞仪在人类样本上 (图 3a). Exp Gerontol (2014) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类; 表 2
BioLegend肿瘤坏死因子抗体（BioLegend, MAB11)被用于被用于流式细胞仪在人类样本上 (表 2). J Infect Dis (2014) ncbi
小鼠 单克隆（MAb11）
  • 流式细胞仪; 人类
BioLegend肿瘤坏死因子抗体（Biolegend, MAb11)被用于被用于流式细胞仪在人类样本上. Tuberculosis (Edinb) (2013) ncbi
文章列表
  1. Mayassi T, Ladell K, Gudjonson H, McLaren J, Shaw D, Tran M, et al. Chronic Inflammation Permanently Reshapes Tissue-Resident Immunity in Celiac Disease. Cell. 2019;176:967-981.e19 pubmed 出版商
  2. Kim C, Hu B, Jadhav R, Jin J, Zhang H, Cavanagh M, et al. Activation of miR-21-Regulated Pathways in Immune Aging Selects against Signatures Characteristic of Memory T Cells. Cell Rep. 2018;25:2148-2162.e5 pubmed 出版商
  3. Aulicino A, Rue Albrecht K, Preciado Llanes L, Napolitani G, Ashley N, Cribbs A, et al. Invasive Salmonella exploits divergent immune evasion strategies in infected and bystander dendritic cell subsets. Nat Commun. 2018;9:4883 pubmed 出版商
  4. Wagner D, Amini L, Wendering D, Burkhardt L, Akyüz L, Reinke P, et al. High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population. Nat Med. 2019;25:242-248 pubmed 出版商
  5. Kelly A, Günaltay S, McEntee C, Shuttleworth E, Smedley C, Houston S, et al. Human monocytes and macrophages regulate immune tolerance via integrin αvβ8-mediated TGFβ activation. J Exp Med. 2018;215:2725-2736 pubmed 出版商
  6. Kuranda K, Jean Alphonse P, Leborgne C, Hardet R, Collaud F, Marmier S, et al. Exposure to wild-type AAV drives distinct capsid immunity profiles in humans. J Clin Invest. 2018;128:5267-5279 pubmed 出版商
  7. Kirkling M, Cytlak U, Lau C, Lewis K, Resteu A, Khodadadi Jamayran A, et al. Notch Signaling Facilitates In Vitro Generation of Cross-Presenting Classical Dendritic Cells. Cell Rep. 2018;23:3658-3672.e6 pubmed 出版商
  8. Li N, van Unen V, Höllt T, Thompson A, van Bergen J, Pezzotti N, et al. Mass cytometry reveals innate lymphoid cell differentiation pathways in the human fetal intestine. J Exp Med. 2018;215:1383-1396 pubmed 出版商
  9. Wolf D, Anto Michel N, Blankenbach H, Wiedemann A, Buscher K, Hohmann J, et al. A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense. Nat Commun. 2018;9:525 pubmed 出版商
  10. Pizzolla A, Nguyen T, Sant S, Jaffar J, Loudovaris T, Mannering S, et al. Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles. J Clin Invest. 2018;128:721-733 pubmed 出版商
  11. Hydes T, Noll A, Salinas Riester G, Abuhilal M, Armstrong T, Hamady Z, et al. IL-12 and IL-15 induce the expression of CXCR6 and CD49a on peripheral natural killer cells. Immun Inflamm Dis. 2018;6:34-46 pubmed 出版商
  12. Vitallé J, Zenarruzabeitia O, Terrén I, Plana M, Guardo A, Leal L, et al. Monocytes Phenotype and Cytokine Production in Human Immunodeficiency Virus-1 Infected Patients Receiving a Modified Vaccinia Ankara-Based HIV-1 Vaccine: Relationship to CD300 Molecules Expression. Front Immunol. 2017;8:836 pubmed 出版商
  13. Ott P, Hu Z, Keskin D, Shukla S, Sun J, Bozym D, et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 2017;547:217-221 pubmed 出版商
  14. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed 出版商
  15. Iampietro M, Younan P, Nishida A, Dutta M, Lubaki N, Santos R, et al. Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection. PLoS Pathog. 2017;13:e1006397 pubmed 出版商
  16. Nelde A, Walz J, Kowalewski D, Schuster H, Wolz O, Peper J, et al. HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy. Oncoimmunology. 2017;6:e1219825 pubmed 出版商
  17. Klinker M, Marklein R, Lo Surdo J, Wei C, Bauer S. Morphological features of IFN-γ-stimulated mesenchymal stromal cells predict overall immunosuppressive capacity. Proc Natl Acad Sci U S A. 2017;114:E2598-E2607 pubmed 出版商
  18. Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445-449 pubmed 出版商
  19. Roberts E, Carnathan D, Li H, Shaw G, Silvestri G, Betts M. Collapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques. PLoS Pathog. 2016;12:e1006135 pubmed 出版商
  20. Izawa K, Martin E, Soudais C, Bruneau J, Boutboul D, Rodriguez R, et al. Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection. J Exp Med. 2017;214:73-89 pubmed 出版商
  21. Spivak A, Larragoite E, Coletti M, Macedo A, Martins L, Bosque A, et al. Janus kinase inhibition suppresses PKC-induced cytokine release without affecting HIV-1 latency reversal ex vivo. Retrovirology. 2016;13:88 pubmed 出版商
  22. Yeap W, Wong K, Shimasaki N, Teo E, Quek J, Yong H, et al. CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes. Sci Rep. 2016;6:34310 pubmed 出版商
  23. Bentzen A, Marquard A, Lyngaa R, Saini S, Ramskov S, Donia M, et al. Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes. Nat Biotechnol. 2016;34:1037-1045 pubmed 出版商
  24. Kagoya Y, Nakatsugawa M, Yamashita Y, Ochi T, Guo T, Anczurowski M, et al. BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models. J Clin Invest. 2016;126:3479-94 pubmed 出版商
  25. He R, Hou S, Liu C, Zhang A, Bai Q, Han M, et al. Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infection. Nature. 2016;537:412-428 pubmed 出版商
  26. van Wilgenburg B, Scherwitzl I, Hutchinson E, Leng T, Kurioka A, Kulicke C, et al. MAIT cells are activated during human viral infections. Nat Commun. 2016;7:11653 pubmed 出版商
  27. Cheng W, van Asten S, Burns L, Evans H, Walter G, Hashim A, et al. Periodontitis-associated pathogens P. gingivalis and A. actinomycetemcomitans activate human CD14(+) monocytes leading to enhanced Th17/IL-17 responses. Eur J Immunol. 2016;46:2211-21 pubmed 出版商
  28. Gadd V, Patel P, Jose S, Horsfall L, Powell E, Irvine K. Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation. PLoS ONE. 2016;11:e0157771 pubmed 出版商
  29. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed 出版商
  30. Neumann B, Shi T, Gan L, Klippert A, Daskalaki M, Stolte Leeb N, et al. Comprehensive panel of cross-reacting monoclonal antibodies for analysis of different immune cells and their distribution in the common marmoset (Callithrix jacchus). J Med Primatol. 2016;45:139-46 pubmed 出版商
  31. Bähr A, Käser T, Kemter E, Gerner W, Kurome M, Baars W, et al. Ubiquitous LEA29Y Expression Blocks T Cell Co-Stimulation but Permits Sexual Reproduction in Genetically Modified Pigs. PLoS ONE. 2016;11:e0155676 pubmed 出版商
  32. Lee Chang C, Bodogai M, Moritoh K, Chen X, Wersto R, Sen R, et al. Aging Converts Innate B1a Cells into Potent CD8+ T Cell Inducers. J Immunol. 2016;196:3385-97 pubmed 出版商
  33. Vallera D, Felices M, McElmurry R, McCullar V, Zhou X, Schmohl J, et al. IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function. Clin Cancer Res. 2016;22:3440-50 pubmed 出版商
  34. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed 出版商
  35. Schnorfeil F, Lichtenegger F, Emmerig K, Schlueter M, Neitz J, Draenert R, et al. T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment. J Hematol Oncol. 2015;8:93 pubmed 出版商
  36. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed 出版商
  37. Talker S, Koinig H, Stadler M, Graage R, Klingler E, Ladinig A, et al. Magnitude and kinetics of multifunctional CD4+ and CD8β+ T cells in pigs infected with swine influenza A virus. Vet Res. 2015;46:52 pubmed 出版商
  38. Bowcutt R, Malter L, Chen L, Wolff M, Robertson I, Rifkin D, et al. Isolation and cytokine analysis of lamina propria lymphocytes from mucosal biopsies of the human colon. J Immunol Methods. 2015;421:27-35 pubmed 出版商
  39. Lu Y, Xue Q, Eisele M, Sulistijo E, Brower K, Han L, et al. Highly multiplexed profiling of single-cell effector functions reveals deep functional heterogeneity in response to pathogenic ligands. Proc Natl Acad Sci U S A. 2015;112:E607-15 pubmed 出版商
  40. Boyle M, Jagannathan P, Bowen K, McIntyre T, Vance H, Farrington L, et al. Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations. J Infect Dis. 2015;212:416-25 pubmed 出版商
  41. Gerner W, Talker S, Koinig H, Sedlak C, Mair K, Saalmüller A. Phenotypic and functional differentiation of porcine αβ T cells: current knowledge and available tools. Mol Immunol. 2015;66:3-13 pubmed 出版商
  42. Zhang P, Lu X, Tao K, Shi L, Li W, Wang G, et al. Siglec-10 is associated with survival and natural killer cell dysfunction in hepatocellular carcinoma. J Surg Res. 2015;194:107-13 pubmed 出版商
  43. Gibbons D, Fleming P, Virasami A, Michel M, Sebire N, Costeloe K, et al. Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants. Nat Med. 2014;20:1206-10 pubmed 出版商
  44. Sueur C, Lupo J, Mas P, Morand P, Boyer V. Difference in cytokine production and cell cycle progression induced by Epstein-Barr virus Lmp1 deletion variants in Kmh2, a Hodgkin lymphoma cell line. Virol J. 2014;11:94 pubmed 出版商
  45. Duggal N, Beswetherick A, Upton J, Hampson P, Phillips A, Lord J. Depressive symptoms in hip fracture patients are associated with reduced monocyte superoxide production. Exp Gerontol. 2014;54:27-34 pubmed 出版商
  46. Krishnan S, Wilson E, Sheikh V, Rupert A, Mendoza D, Yang J, et al. Evidence for innate immune system activation in HIV type 1-infected elite controllers. J Infect Dis. 2014;209:931-9 pubmed 出版商
  47. Marin N, Paris S, Rojas M, Garcia L. Functional profile of CD4+ and CD8+ T cells in latently infected individuals and patients with active TB. Tuberculosis (Edinb). 2013;93:155-66 pubmed 出版商